Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-03-05
1993-08-10
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 50, 514274, 514371, 536 282, 544327, A61K 3170, A61K 31505
Patent
active
052349136
ABSTRACT:
Synergistic combinations of nucleoside derivatives, pharmaceutical formulations containing said combinations and use of the combinations in the treatment of retroviral infections are disclosed.
REFERENCES:
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4837311 (1989-06-01), Tam et al.
patent: 4874751 (1989-10-01), Beacham et al.
patent: 5041449 (1991-08-01), Belleau et al.
patent: 5047407 (1991-09-01), Belleau et al.
patent: 5071983 (1991-12-01), Koszalka et al.
Belleau et al., "Design and Activity of a Novel Class of Nucleoside Analogs Effective Against HIV-1," 5th International AIDS Cong., Jun., 1989, p. 515, Abstr. No. T.C.O.1.
Rooke et al., "Biological Comparison of Wild-Type and Zidovudine-Resistant Isolates of Human Immunodeficiency Virus Type 1 from the Same Subjects: Susceptibility and Resistance to Other Drugs," Antimicrob. Agents Chemother., 35(5), 988-991 (1991).
Beach, et al., "Synthesis of (-)-L-Beta-BCH-189 from L-Glucose and its Anti-HIV and anti-HBV Activity," Abstracts of Papers from the 203rd ACS National Meeting, vol. 203(1-3), #50 (1992).
Greenberg, et al., "Metabolism, Toxicity and Anti-HIV Activity of 2'-Deoxy-3'-Thia-Cytidine (BCH-189) in T and B Cell Lines," Annals of the New York Academy of Sciences, vol. 616, pp. 517-518 (1990).
Beach, et al., "Synthesis of Enantiomerically Pure (2'R,5'S)-(-)1-{2-(Hydroxymethyl)oxathiolan-5-yl}cytosine as a Potent Antiviral Agent Against Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV)," J. Org. Chem. 57, 2217-2219 (1992).
Robbins, M. J., et al., Nucleic Acid Chemistry, Part 2, J. Wiley and Sons, New York, 895-900 (1978).
Duschinsky, R., Nucleic Acid Chemistry, Part 1, J. Wiley and Sons, New York, 43-46 (1978).
Schleicher and Schuell, S&S, 10 Optical Ave., Keene, N.H. 03431, Publication No. 700, 1987.
Southern, E. M., J. Mol. Biol, 98, 504-17 (1975).
Norbeck et al., Tetrahedron Letters, vol. 30, No. 46, pp. 6263-6266 (1989).
Abstract No. 90-248406/33, Eastman Kodak Co., EP-382-519-A.
Abstract No. 89-302435/42, IAF Biochem. Int., Inc., EP337-713-A.
Abstract No. 83654 c/47, Tanabe Seiyaku KK, J5 5130-975.
Abstract No. 99-314460/42, R. T. Walker, EP-392-791-A.
Abstract, Patent and Literature Search, IAF Biochem. Int., Inc.
Averett, D. R., J. Virol. Methods, 23, 263-276 (1989).
Elion, G. et al., J. Biol. Chem., 208, 477-88 (1954).
Kassianides, et al., "Effects of 2',3'-dideoxycytidine on Duck Hepatitis B Virus,.sbsp.qGastroenterology 94 (5), part 2, p. A552 (1988).
Doong, et al., "Inhibition of the Replication of Hepatitis B Virus in vitro by 2',3'-dideoxy-3'thiacytidine and Related Analogues," Abstracts of the ICAAC, Abstract No. 496, p. 181 (Aug. 1991).
Soudeyns, H. et al., Antimicrob. Agents Chemother., 35 (7), 1386-90 (1991).
Choi, W. B. et al., J. Am. Chem. Soc., 113 (24), 9377-9 (1991).
Tyle, P., Pharmaceutical Research 3 (6), 318-26 (1986).
Halongquist, E. G. and Hibbert, H., Can. J. Research, 8, 129 1933.
Hesse, G. and Jorder, I., Chem. Ber. 85, 924, 932 (1952).
Busso et al., "Nucleotide Dimers Suppress HIV Expression In Vitro," AIDS Research and Human Retroviruses, 4(6), 449-455 (1988).
Doong et al., "Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogs," Proc. Nat. Acad. Sci. USA, 88(19), 8494-8499 (1991); Chem. Abstr., 115, p. 27, Abstr. No. 269987z (1991); only abstract provided.
K. J. Divakar, et al., J. Chem. Soc., Perkins 1, 1982, pp. 1171-1176, 4-(1,2,4-Triazol-1-yl)-and 4-(3-Nitro-1,2,4-triazol-1-yl)-1-(.beta.-D-2,3,5-tri-O-acetylarabinofuraro syl)pyrimidin-2(1H)-ones. Valuable Intermediate in the Systhesis of Derivatives of 1-(.beta.-D-Arabinofuranosyl)cytosine (Ara-C).
Wing L. Sung, Nucleic Acids Research, vol. 9, No. 22, 1981, Synthesis of 4-triazolopyrimidinone nucleotide and its application in synthesis of 5-methylcytosine containing oligodeoxyribonucleotides, pp. 6139-6151.
Sells, et al., Proc. Natl. Acad. Sci., USA, vol. 84, Feb., 1987, pp. 1005-1009, Cell Biology, Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.
Sells, et al., Journal of Virology, vol. 62, No. 8, Aug., 1988, Replicative Intermediates of Hepatitis B Virus in HepG2 Cells That Produce Infectious Virions, pp. 2836-2844.
Abstract, Patent and literature search for 2'-deoxy-3'-thianucleoside analogues, as disclosed in EP 382526 (IAF Biochemical Int., Inc.).
Virology (Part 1), 5th International AIDS Congress, Jun. 1989.
Furman, Jr. Phillip A.
Painter, III George R.
Brown Donald
Brown Johnnie R.
Burroughs Wellcome Co.
Crane L. Eric
Green Hannah O.
LandOfFree
Antiviral nucleoside combination does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral nucleoside combination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral nucleoside combination will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1725229